Levy Family Fund


1. Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors

2. Absence of cardiotoxicity with prolonged treatment and large accumulating doses of pegylated liposomal doxorubicin

3. Clinical outcome of neoadjuvant chemotherapy for advanced ovarian cancer


4. Metformin Increases E-cadherin in Tumors of Diabetic Patients With Endometrial Cancer and Suppresses Epithelial-Mesenchymal Transition in Endometrial Cancer Cell Lines

5. Minimizing pain medication use and its associated costs following robotic surgery


6. Suppression of Homologous Recombination by insulin-like growth factor-1 inhibition sensitizes cancer cells to PARP inhibitors

7. Chemotherapy reduces PARP1 in cancers of the ovary: implications for future clinical trials involving PARP inhibitors

8. Health-Related Quality of Life Following Robotic Surgery: A Pilot Study

9. Current Role of Sentinel Lymph Node Mapping in Endometrial Cancer

10. Comparing indocyanine green, technetium, and blue dye for sentinel lymph node mapping in endometrial cancer


11. Impact of robotics on the outcome of elderly patients with endometrial cancer

12. Health-Related Quality of Life Following Robotic Surgery: A Pilot Study

13. Anti-diabetic doses of metformin decrease proliferation markers in 2 tumors of patients with end

14. Prospective Quality of Life Outcomes Following Robotic Surgery in Gynecologic Oncology


Page last updated on 

We always seek feedback to make our site better.